Synthesis, Structural Characterization and Cancer Cell Cytotoxic Activity of Vadimezan Hydrazones


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

New vadimezan hydrazones were synthesized as E/Z isomers and characterized by IR, 1H NMR, MS, and HRMS techniques; the ratio of isomers was analyzed by NOESY spectra. All compounds were evaluated for their cytotoxic activities against endometrial Ishikawa, lung A549 and NCI-460, chorion Bewo, cervical HeLa and Siha, breast MCF-7, leukemia HL-60, liver BEL-7402, and stomach BGC-823 cancer cell lines in vitro by standard MTT assay. The preliminary pharmacological results indicated that compound 5c exhibited most promising cytotoxic activity against NCI-460 cell line with IC50 value of 7.01 ± 0.53 μM.

About the authors

Shi-Jie Zhang

Science Research Department, Zhejiang Chinese Medical University

Author for correspondence.
Email: medchem@zcmu.edu.cn
China, Hangzhou, 310053

Feng Xu

Biopharmaceutical Research and Development Center, Taizhou Vocational & Technical College

Email: medchem@zcmu.edu.cn
China, Taizhou, 31800

Qiu-Fu Ge

Hangzhou Minsheng Pharmaceutical Group Co., Ltd.

Email: medchem@zcmu.edu.cn
China, Hangzhou, 310011

Hai-Bo Li

Nantong Center for Disease Control and Prevention

Email: medchem@zcmu.edu.cn
China, Nantong, 226007

Wei-Xiao Hu

College of Pharmaceutical Science, Zhejiang University of Technology

Email: medchem@zcmu.edu.cn
China, Hangzhou, 310032


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies